PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
53.38%
Net income growth exceeding 1.5x Healthcare median of 5.07%. Joel Greenblatt would see it as a clear outperformance relative to peers.
6.19%
D&A growth of 6.19% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
102.44%
Deferred tax growth of 102.44% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
-15.99%
SBC declines yoy while Healthcare median is 0.00%. Seth Klarman would see a near-term advantage in less dilution unless new hires are needed.
-86.82%
Working capital is shrinking yoy while Healthcare median is -61.94%. Seth Klarman would see an advantage if sales remain robust.
193.94%
AR growth of 193.94% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or more relaxed credit if revenue is not matching it.
424.16%
Inventory growth of 424.16% while Healthcare median is zero at 0.00%. Walter Schloss would question if expansions or new product lines require extra stock.
-203.26%
AP shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see better immediate cost coverage if top-line remains intact.
-109.13%
Other WC usage shrinks yoy while Healthcare median is -32.09%. Seth Klarman would see an advantage if top-line is stable or growing.
-105.49%
Other non-cash items dropping yoy while Healthcare median is 7.94%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
-136.34%
Negative CFO growth while Healthcare median is -17.68%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
66.53%
CapEx growth of 66.53% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or upgrades behind the difference.
1535.04%
Acquisition growth of 1535.04% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or partial deals fueling that difference.
-3624.90%
Investment purchases shrink yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term cash advantage if no high-return opportunities are missed.
No Data
No Data available this quarter, please select a different quarter.
-278.96%
We reduce “other investing” yoy while Healthcare median is 0.00%. Seth Klarman would see a potential advantage in preserving cash if top-line growth is not harmed.
-246.65%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
89.48%
Debt repayment growth of 89.48% while Healthcare median is zero at 0.00%. Walter Schloss wonders if expansions or a shift in capital structure drive that difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.